| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 135, 373-378, Copyright © 1994 by Endocrine Society
ARTICLES |
S Capsoni, M Viswanathan, AM De Oliveira and JM Saavedra
Section on Pharmacology, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892.
The aims of this study were to characterize the melatonin receptors in rat brain arteries forming the circle of Willis. Saturation studies performed using in vitro autoradiography and [125I]iodomelatonin revealed the presence of two binding sites: one with a Kd of 13 pM, and the second characterized by a Kd of 832 pM. Coincubation with a nonhydrolyzable guanine nucleotide analog [guanosine-5'-O-(3- thiotriphosphate)] inhibited 2-[125I]iodomelatonin binding in a concentration-dependent manner, whereas adenine nucleotide adenosine-5'- O-(3-thiotriphosphate) was ineffective. In saturation studies performed in the presence of guanosine-5'-O-(3-thiotriphosphate), the high affinity site was no longer detectable, and the affinity of the receptor was decreased to the high picomolar range. Melatonin, at nanomolar concentrations, was able to inhibit forskolin-stimulated cAMP production in rat circle of Willis arteries. Preincubation with pertussis toxin counteracted the effect of melatonin. Our results demonstrate that melatonin receptors in rat cerebral arteries are linked to their second messenger through a pertussis toxin-sensitive G- protein, similar to what has been described for melatonin receptors in different areas of vertebrate brain.
This article has been cited by other articles:
![]() |
T. J. Bartness, G. E. Demas, and C. K. Song Seasonal Changes in Adiposity: the Roles of the Photoperiod, Melatonin and Other Hormones, and Sympathetic Nervous System Experimental Biology and Medicine, June 1, 2002; 227(6): 363 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vandeputte, P. Giummelly, J. Atkinson, P. Delagrange, E. Scalbert, and C. Capdeville-Atkinson Melatonin potentiates NE-induced vasoconstriction without augmenting cytosolic calcium concentration Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H420 - H425. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rich, G. Farrugia, and J. L. Rae Effects of melatonin on ionic currents in cultured ocular tissues Am J Physiol Cell Physiol, April 1, 1999; 276(4): C923 - C929. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. VANECEK Cellular Mechanisms of Melatonin Action Physiol Rev, July 1, 1998; 78(3): 687 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cagnacci, S. Arangino, M. Angiolucci, E. Maschio, and G. B. Melis Influences of melatonin administration on the circulation of women Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1998; 274(2): R335 - R338. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Mahle, G. D. Goggins, P. Agarwal, E. Ryan, and A. J. Watson Melatonin Modulates Vascular Smooth Muscle Tone J Biol Rhythms, December 1, 1997; 12(6): 690 - 696. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |